%0 Journal Article
%K HPMA (N-2-hydroxypropylmethacrylamide)
%K PLGA
%K nanoparticles (NPs)
%K rifampicin (RMP)
%K Solubility
%K tuberculosis (TB)
%B Pharmaceutical research
%D 2018
%G eng
%N 1
%P 19
%R 10.1007/s11095-018-2543-x
%T HPMA-PLGA Based Nanoparticles for Effective In Vitro Delivery of Rifampicin.
%V 36
%1 <p>http://www.ncbi.nlm.nih.gov/pubmed/30511238?dopt=Abstract</p>